LS.com homepage  •   LS.com FAQ  •   Resources
In the media  •   Articles  •   WIKI
It is currently 26 May 2013, 05:01

All times are UTC [ DST ]


Forum rules


This is the one of the guest-viewable discussion areas. If you haven't already, sign up as a user (everything is, and always will be, completely free)! Users can engage in discussion in both guest-viewable and member-only subforums. There's also an arcade.

Please post in good faith. We support freedom of speech here but deliberately inflammatory posts will be deleted. Use common sense when writing posts and be sure to read the guidelines (and weep) before posting.



Post new topic Reply to topic  [ 9 posts ] 
Author Message
PostPosted: 06 Jun 2012, 11:43 
Offline
Elite Contributor
User avatar

Joined: 23 Apr 2009, 14:52
Posts: 2539
Location: Tvashtar Paterae
Thanks: 858
Thanked:
469 times in 304 posts
Just reading an article in Scientific American:

http://www.scientificamerican.com/artic ... f-the-clap

From Maryn McKenna's blog:

In my latest column at Scientific American, I take a look at the recent rapid increase in antibiotic resistance in gonorrhea. I’ve explored this problem in two earlier posts here: Resistance to cephalosporins, the last class of antibiotics that are reliable, cheap, and effective enough to not require a follow-up visit, first emerged in Japan in 1999 and began spreading around the globe from there, arriving in California in 2008 and moving across to the East Coast by last year.

That’s bad enough, because while we may think of gonorrhea as a minor illness long ago eclipsed in seriousness by HIV/AIDS, it remains one of the most-reported diseases in the country, with more than 600,000 known cases per year. Gonorrhea that goes untreated is personally and socially costly, causing pelvic inflammatory disease, infertility and widespread organ damage. And when resistance is not detected, it is possible for gonorrhea to go, effectively, untreated, because the drugs that are given to cure the infection will not work against the resistant form.

But what turns out to be worse — and here is where the unintended consequences come in — is that public health’s attempts to track STDs, as an important public health priority, may have enabled the spread of resistant gonorrhea. That’s because the cheap rapid tests that allow the disease to be diagnosed quickly don’t detect resistance. From my column:

For years standard practice has been to quickly identify an infection, dole out the appropriate treatment and then move on to the next patient. If symptoms return, the assumption has been that the patient was reinfected. Experts now say that such patients may in fact have harbored resistant bacteria that were never killed in the first place — bacteria that the patients possibly spread to others.

Physicians would not have recognized that they were dealing with increasingly resistant bacteria, because the rapid tests most commonly used to diagnose sexual infections cannot identify resistant organisms. Instead the tests look for a DNA segment that is unique to gonorrhea, destroying the bacteria in the process. Identifying resistance requires intact living bacteria that researchers can grow in a lab dish and expose to antibiotics to see which drugs work or do not.

STD control — for many decades, one of the most effective of all public health’s accomplishments — was built on quick outpatient treatment. Public health could afford to fund the apparatus of STD control because the drugs were inexpensive and the clinical encounters were uncomplicated. But identifying and tracking resistant gonorrhea could change STD control from something relatively affordable to something that isn’t even close. From my column:

Routinely testing patients for resistant strains with the culture tests instead of rapid tests would be costly and time-consuming. But in [a] February New England Journal editorial, lead author Gail Bolan, director of the CDC’s division of STD prevention, argues that it is necessary. She also recommends retesting patients after treatment to make sure the infection is gone.

Doctors who treat sexually transmitted infections say that although such changes are sensible, they are not easy. Collecting bacterial samples for analysis requires supplies that most offices do not keep on hand, says Melanie Thompson, executive director of the AIDS Research Consortium of Atlanta, which also does STD testing. “A health care provider who suspected a resistant case would have to recognize it,” she explains, “contact the CDC or state health department to report it, go about getting the materials and then get the patient back in to give a sample.”

The need to invest in new testing regimens and new treatment arrangements — in which patients must return for multiple visits and be retested to see whether their infections have persisted — comes at a particularly bad time for STD control. Over the past few years, according to the National Coalition of STD Directors, 69 percent of state STD programs suffered budget cuts.

The situation is considered sufficiently alarming that the CDC will hold a Grand Rounds on resistant gonorrhea on May 15 (accessible to the public by webcast as far as I can tell; details are here.) As the agency’s STD director, Bolan, and two academics said in that February NEJM editorial referenced above: “There is much to do, and the threat of untreatable gonorrhea is emerging rapidly.”

Link: http://www.wired.com/wiredscience/2012/ ... gonorrhea/

_________________
"He saw towers and walls in nighted depths under the sea, and vortices of space where wisps of black mist floated before thin shimmerings of cold purple haze. - H. P Lovecraft "The Haunter of the Dark".

"There has been no genetic change since we were hunter-gatherers, but deep in the mind of modern man is a simple hunter-gatherer rule: strive to acquire power and use it to lure women who will bear heirs; strive to acquire wealth and use it to buy affairs with other men’s wives who will bear bastards . . . Wealth and power are means to women; women are means to genetic eternity.

Likewise, deep in the mind of modern woman is the same hunter-gatherer calculator, too recently evolved to have changed much: strive to acquire a provider husband who will invest food and care in your children; strive to find a lover who can give those children first-class genes. Only if she is very lucky will they both be the same man . . . Men are to be exploited as providers of parental care, wealth and genes." - Matt Ridley "The Red Queen"

"Humor won’t save you; it doesn’t really do anything at all. You can look at life ironically for years, maybe decades; there are people who seem to go through most of their lives seeing the funny side, but in the end, life always breaks your heart. Doesn’t matter how brave you are, how reserved, or how much you’ve developed a sense of humor, you still end up with your heart broken. That’s when you stop laughing. In the end there’s just the cold, the silence and the loneliness. In the end, there’s only death." - Houellebecq


Top
 Profile  
Thanks  
The following users would like to thank Erebus for the above post:
darwin
PostPosted: 06 Jun 2012, 18:34 
Offline
Elite Contributor

Joined: 28 Aug 2011, 17:55
Posts: 2359
Thanks: 979
Thanked:
219 times in 163 posts
Know what's even more creepy? The two pahtalogical strains of Neisseria gonorrhoeae that cause the disease are also capable of transforming the hosts DNA. That is they are able to put their DNA into your DNA, or take some of your's back into themselves.


Top
 Profile  
Thanks  
PostPosted: 06 Jun 2012, 18:45 
Offline
Elite Contributor

Joined: 28 Aug 2011, 17:55
Posts: 2359
Thanks: 979
Thanked:
219 times in 163 posts
For those of you who don't know, this is how dry science writing is, so F you if you think Suzie Rotten Crouch has the patience for it.

Spoiler: show
Opportunity and Means: Horizontal Gene Transfer from the Human Host to a Bacterial Pathogen

Mark T. Anderson and
H. Steven Seifert

+ Author Affiliations

Department of Microbiology-Immunology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA

Address correspondence to H. Steven Seifert, h-seifert@northwestern.edu.

Editor Stanley Maloy, San Diego State University


Next Section
ABSTRACT

The acquisition and incorporation of genetic material between nonmating species, or horizontal gene transfer (HGT), has been frequently described for phylogenetically related organisms, but far less evidence exists for HGT between highly divergent organisms. Here we report the identification and characterization of a horizontally transferred fragment of the human long interspersed nuclear element L1 to the genome of the strictly human pathogen Neisseria gonorrhoeae. A 685-bp sequence exhibiting 98 to 100% identity to copies of the human L1 element was identified adjacent to the irg4 gene in some N. gonorrhoeae genomes. The L1 fragment was observed in ~11% of the N. gonorrhoeae population sampled but was not detected in Neisseria meningitidis or commensal Neisseria isolates. In addition, N. gonorrhoeae transcripts containing the L1 sequence were detected by reverse transcription-PCR, indicating that an L1-derived gene product may be produced. The high degree of identity between human and gonococcal L1 sequences, together with the absence of L1 sequences from related Neisseria species, indicates that this HGT event occurred relatively recently in evolutionary history. The identification of L1 sequences in N. gonorrhoeae demonstrates that HGT can occur between a mammalian host and a resident bacterium, which has important implications for the coevolution of both humans and their associated microorganisms.

IMPORTANCE The interactions between microbes and their hosts are relevant to several aspects of biology, including evolution, development, immunity, and disease. Neisseria gonorrhoeae serves as a particularly informative model for this interaction because it has exclusively coevolved with humans and is not known to be found in any other environment. In addition, investigation of the evolutionary relationship between N. gonorrhoeae and humans has practical implications, since gonorrhea is a prevalent sexually transmitted infection worldwide. This study was undertaken to characterize the horizontal transfer of genetic information from humans to N. gonorrhoeae, an event that has been scarcely recognized between any mammalian host and bacterial pathogen. Here we provide evidence that this genetic exchange was the result of a recent evolutionary event that has been propagated within the gonococcal population.
Previous SectionNext Section
INTRODUCTION

Evolution of asexual organisms can occur by the accumulation and vertical transmission of mutations in an existing genetic repertoire or through the acquisition of novel genetic determinants by horizontal gene transfer (HGT). HGT has the capacity to facilitate the acquisition of complex physiological functions (1) in a single molecular event and has been estimated to account for up to 17% of the total genetic material found in Escherichia coli (2). HGT must therefore be regarded as an important force in the adaptation of species. HGT is particularly well known to have a diverse impact on bacterial physiology, with examples in the literature describing the horizontal acquisition of novel biosynthetic (3), virulence (1), and antibiotic resistance (4) functions by diverse bacterial species. Despite the countless interactions between commensal or pathogenic bacteria and their cognate hosts and the ever-increasing amount of available genomic sequence data, examples of bacterial integration of host genetic information are exceedingly rare. The rarity of HGT from host to bacterium may be due, in part, to potential barriers such as restriction and modification functions, the availability of genetic material, and the fitness cost of deleterious HGT events. However, such an event has the potential to impact the evolution of both the host and the microbe.

Neisseria gonorrhoeae is the causative agent of the sexually transmitted infection gonorrhea. N. gonorrhoeae is naturally competent for transformation and has incorporated DNA from related neisserial species (5, 6) and more divergent bacterial species (7) into its genome. Recombination of exogenous DNA occurs efficiently in N. gonorrhoeae, and it is postulated that this process plays an important role in the microevolution of the organism (8, 9). N. gonorrhoeae has a long and exclusive evolutionary history with its human host, and infection is typically localized to the urogenital tract. Therefore, sources of foreign DNA available to the gonococcus are limited to coinhabiting microorganisms or the host itself. Mammalian genomes contain numerous copies of the long interspersed nuclear element (LINE) L1. Full-length human L1 elements encode a nucleic acid binding protein and a multidomain protein with endonuclease and reverse transcriptase activities (10), which together facilitate mobilization of the element via retrotransposition (11). This work establishes the presence of N. gonorrhoeae genome sequences with strong identity to human LINE L1 (10) and characterizes the results of this HGT event.
Previous SectionNext Section
RESULTS

The genome sequences of 14 N. gonorrhoeae clinical isolates were recently determined and made publically available by the Neisseria gonorrhoeae group Sequencing Project (http://www.broadinstitute.org/), adding to the existing genome sequences of FA1090 and NCCP11945 (12). Analysis of the unfinished assemblies identified a 685-bp fragment present in strains FA6140 (supercontig 29, positions 23818 to 24502), DGI18 (supercontig 24, positions 24037 to 24721), and PID24 (supercontig 27, positions 23854 to 24538) that exhibited 98 to 100% identity to copies of human retrotransposable element L1. This Neisseria L1 sequence (nL1) also exhibits strong similarity to LINEs from other primates (e.g., Pan troglodytes), but since humans are the only known natural host for N. gonorrhoeae, it is likely that the HGT event that yielded nL1 occurred in humans. The nL1 fragment is identical among the FA6140, DGI18, and PID24 Neisseria strains and occupies the same insertion site (Fig. 1). The nL1 element includes the coding sequence for the first 164 amino acids of the L1 open reading frame 1 (ORF1) nucleic acid binding protein (13) and 192 bases of the L1 5′ untranslated region upstream of ORF1. This region of the ORF1 protein contains a coiled-coil domain that is required for trimerization of the murine ORF1 protein and the first 8 amino acids of a 96-residue RNA recognition motif (14). The insertion site in the gonococcal genome is located 14 bp upstream of a copy of the phage-associated transposase irg4 (15, 16). This genetic region also contains a 24-bp inverted repeat, one of which is interrupted by the nL1 insertion (Fig. 1). Although repeat sequences and mobile genetic elements are often associated with HGT, comparison of nL1-positive and nL1-negative genomes yields no evidence that either the putative Nf4-G4 prophage or the inverted repeat was directly involved in the acquisition of nL1.
FIG 1
View larger version:

In this page
In a new window

Download as PowerPoint Slide

FIG 1

Map of the nL1 fragment in N. gonorrhoeae. (A) Schematic of a full-length L1 element. (B) The 10 terminal nucleotides of the 685-bp nL1 insertion are shown in their corresponding locations on the L1 element (GenBank accession no. U09116.1). (C) The nL1 insertion site within the N. gonorrhoeae genome is denoted by the bold arrow and is 14 bp upstream of the irg4 start codon. The specific irg allele was identified using the nomenclature established for the FA1090 annotation (16). The first 6 amino acids of Irg4 are shown. Two 24-bp inverted repeats in the gonococcal genome are underlined, and the highlighted sequence designates one terminus of the Nf4-G4 prophage sequence that includes the irg4 ORF (15). UTR, untranslated region.

Contamination of DNA sequencing samples has previously accounted for the false identification of LINE sequences in human-associated microorganisms (17). To test whether the presence of nL1 was the result of contamination introduced during the sequencing or purification of gonococcal DNA, independently prepared genomic DNA from the sequenced N. gonorrhoeae isolates was assayed for the presence of nL1 by PCR. Multiple reactions containing primer combinations specific to the nL1 sequence and flanking DNA verified the presence of nL1 in the genomic location predicted by the sequences (Fig. 2A to D). Sequencing of nL1-containing PCR products confirmed this result and the composition of nL1 as reported in the genome sequences of all three strains (data not shown). DNA hybridizations using a probe generated from human L1 sequences also confirmed that strains FA6140, DGI18, and PID24 contained nL1 and that this fragment was not located at an alternative site in the genomes of the remaining 12 strains from Fig. 2 (data not shown). Together, these analyses conclusively demonstrate that the presence of L1 DNA in strains PID24, DGI18, and FA6140 is attributable to HGT and is not an artifact of genome sequencing.
FIG 2
View larger version:

In this page
In a new window

Download as PowerPoint Slide

FIG 2

PCR amplification of the nL1 fragment in N. gonorrhoeae isolates and nL1 transcript detection by RT-PCR. Purified genomic DNA from sequenced gonococcal isolates and human chromosomal DNA were used as templates for PCR amplification of the nL1 fragment and L1. (A) Primers IS1106for and IRGrev anneal to sequences flanking the nL1 insertion site and yield products of 1,090 and 405 bp for nL1-positive and nL1-negative alleles, respectively. Neither product was detected in DNA from strain SK-93-1035, but this isolate is not predicted to harbor the nL1 fragment. (B) Reactions using primers LINEfor and LINErev, which anneal to sequences internal to the human L1 element and the nL1 fragment. Combinations of flanking and internal primers LINErev and IS1106for (C) or LINEfor and IRGrev (D) were used to confirm the genomic location of nL1. The background bands visible in panels A and C are not due to nL1 sequence amplification, since all of the strains shown here, except PID24, DGI18, and FA6140, were also determined to be nL1 negative by DNA hybridization. Total RNA from nL1-containing isolates (DGI18, PID24, PID334, and FA6140) was used as the template in RT reaction mixtures containing (+RT) or lacking (−RT) reverse transcriptase. The resulting cDNA was amplified with internal nL1 primers L1for and L1rev. Isolates FA1090, MS11, and NCCP11945 lack the L1 fragment and were included as negative controls. Purified genomic DNA from isolate PID334 was used as a positive control. Products were obtained with cDNA generated from positive-strand (E) and negative-strand (F) RNA transcripts.

To assess the frequency of nL1 in the population, a diverse collection of Neisseria strains, isolated at different times and locations, were screened for the presence of nL1 using a combination of molecular and bioinformatic techniques (see Table S1 in the supplemental material). Four additional nL1-positive N. gonorrhoeae strains were identified by this analysis (97G181, ATCC 49226, PID334, and WHO I) and determined to harbor a 685-bp sequence identical to that reported for the sequenced nL1-positive strains. Therefore, the nL1 allele occurred at a frequency of ~11% among the 62 N. gonorrhoeae strains that were included in this study. Interestingly, the different disease manifestations of N. gonorrhoeae infection (uncomplicated infection, pelvic inflammatory disease, disseminated gonococcal infection) were all represented among the nL1-positive strains identified here. Although closely related members of the genus Neisseria are also exclusively associated with human infection, examination of 212 Neisseria meningitidis isolates and 19 commensal Neisseria isolates produced no evidence of the nL1 fragment (see Table S1 in the supplemental material). Assuming that the frequency of occurrence is similar in N. meningitidis and N. gonorrhoeae, the probability of observing zero nL1 events in the N. meningitidis population tested is 1.9E−11, since the number should follow a binomial distribution with n = 212 and P = 0.11. The lack of nL1 sequences in the highly genetically related species N. meningitidis suggests that the acquisition of nL1 by N. gonorrhoeae was a recent evolutionary event that occurred subsequent to the divergence of N. meningitidis and N. gonorrhoeae. The identification of nL1 in gonococci but not meningococci may reflect differences in the species-specific interactions between bacteria and host cells, the availability of host DNA during infection with N. gonorrhoeae versus N. meningitidis, or most likely an event that occurred after the two species diverged.

The absolute conservation of the nL1 sequence among the seven positive isolates is striking and suggests that this locus is under selective pressure or has not had sufficient time to degenerate. Reverse transcription (RT)-PCR using total RNA and internal L1 primers detected transcripts containing the nL1 sequence originating from both strands of DNA (Fig. 2E and F). Therefore, the HGT event that yielded nL1 has the potential to produce a novel gene product and may contribute to the observed sequence conservation. However, because the frequency of nL1 occurrence in the tested population is modest, any selective force conferred by nL1 may be small and difficult to identify experimentally. During laboratory culture, no consistent gross phenotypic differences between nL1-positive and nL1-negative strains were observed.

In addition to selective pressure, clonal expansion could also account for the observed lack of variation of the nL1 allele among N. gonorrhoeae isolates. Multilocus sequencing typing (MLST) (18) was used to assess the relatedness of four nL1-positive isolates compared to 12 confirmed L1-negative isolates for which allele sequences were available. Strains DGI18 and PID24 have identical MLST profiles belonging to sequence type 8418 and may represent clonal expansion of the nL1 allele (Table 1). However, strains FA6140 and PID334 have sequence types divergent from both sequence type 8418 and each other. Since three distinct sequence types are represented among the four nL1 strains analyzed, either the presence of the nL1 fragment in these strains was the result of multiple identical HGT events or, more likely, an initial acquisition of nL1 from humans was subsequently transferred horizontally between gonococcal strains.
View this table:

In this window
In a new window

TABLE 1

MLST profiles of the N. gonorrhoeae strains used in this study
Previous SectionNext Section
DISCUSSION

The high level of identity between human L1 and nL1 sequences, combined with its absence in closely related Neisseria species, suggests that this HGT event happened relatively recently in evolutionary history and/or that the nL1 region is under strong selective pressure. In addition, the low penetrance of nL1 within the gonococcal population is consistent with the hypothesis that nL1 was acquired recently from humans. Since numerous different L1 copies exist in any one human genome, including ones that contain sequences identical to nL1 (GenBank accession no. AC013546), analysis based on the accumulation of synonymous and nonsynonymous substitutions relative to a donor sequence is not feasible. N. gonorrhoeae can be found intracellularly and extracellularly associated with neutrophils and epithelial cells and thus has the opportunity to encounter host DNA during infection (19, 20). The natural competence of N. gonorrhoeae provides the bacterium with the means to acquire exogenous DNA, and the fact that the signature Neisseria DNA uptake sequence is not absolutely required for internalization of exogenous DNA (21) increases the probability of this event’s occurrence. Although N. gonorrhoeae can invade and replicate within host cells, there is no evidence for nuclear association, making interaction with host DNA in live cells unlikely. A potential scenario in which HGT between humans and intracellular N. gonorrhoeae could more readily occur is after an apoptotic (22) or necrotic event in which the host DNA is fragmented or disrupted within the dying cell. Alternatively, the active secretion of neutrophil extracellular traps (23) provides a means by which host DNA could become accessible to extracellular N. gonorrhoeae.

The mechanism by which this foreign genetic material was incorporated into the N. gonorrhoeae genome is a matter of speculation. Comparison of the insertion site between nL1-positive and nL1-negative isolates demonstrates that the recombined fragment is the result of a simple insertion with no loss or gain of flanking chromosomal information (Fig. 1). Mobilization of L1 elements within the nuclei of host cells occurs via target-primed RT (11), which requires the function of ORF1p and ORF2p and results in target site duplication. No such signature duplication is present near the nL1 site, and retrotransposition is unlikely to account for the insertion of nL1 into the N. gonorrhoeae genome. There is no homology between the gonococcal insertion site and the L1 sequences flanking the nL1 fragment, suggesting that direct recombination after transformation is also an unlikely mechanism for the integration of nL1. Therefore, we postulate that nonhomologous end joining (NHEJ) could have occurred between a fragmented copy of L1 and the recipient region of the N. gonorrhoeae genome. Although N. gonorrhoeae lacks the NHEJ machinery possessed by some bacteria, alternative pathways of low-frequency NHEJ that have the potential to mediate HGT of exogenous sequences have been proposed (24).

Regardless of the mechanism by which HGT occurred, it is possible that nL1 has an effect on the physiology of N. gonorrhoeae by way of residual activity of the truncated ORF1 protein (if produced) or via polar effects of the insertion itself. More significantly, though, the identification of human sequences within the N. gonorrhoeae genome has important implications for modeling of the generation of genetic diversity and evolution of this and other obligate human pathogens and establishes that HGT can occur between a mammalian host and an associated microorganism.
Previous SectionNext Section
MATERIALS AND METHODS

Bacterial strains and culture conditions.The Neisseria isolates used in this study and their sources are listed in Table S1 in the supplemental material. N. gonorrhoeae and commensal Neisseria species were grown on gonococcal medium base (Difco) containing Kellogg supplements as described previously (25). N. meningitidis strains were cultivated on gonococcal medium supplemented with 1% IsoVitaleX (Becton Dickinson). Bacteria used for the preparation of RNA were grown to exponential phase as described previously (25) in GCBL broth (1.5% proteose peptone no. 3 [Difco], 0.4% K2HPO4, 0.1% KH2PO4, 0.1% NaCl) supplemented with 1% IsoVitaleX.

Detection of the nL1 allele.All of the oligonucleotide primers used in this study are listed in Table S2 in the supplemental material. Genomic DNA was purified on QIAamp columns (Qiagen) and used for PCR and slot blot hybridizations. The nL1 genotype of the N. gonorrhoeae strains listed in Fig. 2 was established using the following primer combinations: IS1106for and IRGrev, LINEfor and LINErev, IS1106for and LINErev, and LINEfor and IRGrev. All other Neisseria isolates screened by PCR as reported in Table S1 in the supplemental material were screened by the LINEfor and LINErev primer pair at minimum. PCR products were sequenced by the Northwestern University Genomics Core Facility. A sampling of isolates of each Neisseria species screened was analyzed by slot blot hybridization using a 541-bp probe PCR amplified from human chromosomal DNA using primers LINEfor and LINErev. The product was labeled with digoxigenin-dUTP via the random-primed method (Roche), and hybridizations were performed using standard techniques. The binomial distribution was used to determine the probability of observing zero nL1 events in N. meningitidis based on the N. gonorrhoeae frequency and assuming equivalent rates. The Northwestern University Biostatistics Collaboration Center assisted with the statistical analysis.

RT-PCR.Total RNA was purified from N. gonorrhoeae cultures using the RNeasy kit (Qiagen) and treated with RQ1 DNase (Promega) to remove genomic contamination. The LINEfor and LINErev oligonucleotides were used to prime cDNA synthesis using Superscript III reverse transcriptase (Invitrogen) according to the manufacturer’s recommendations. Internal nL1 primers L1for and L1rev were used to PCR amplify cDNA products.

MLST.Seven housekeeping genes; abcZ, adk, aroE, fumC, gdh, pdhC, and pgm, were used to establish the sequence types of N. gonorrhoeae strains as described previously (18), with the exception of the oligonucleotide primers that were used for amplification and sequencing of MSLT alleles. Allele numbers were assigned by querying the Neisseria MLST database (18) using existing genomic sequences when available. The MLST primers listed in Table S2 in the supplemental material were used to PCR amplify and sequence (both strands) all alleles from strain PID334 and any other allele not previously established in the database. The profiles of all of the strains listed in Table 1 have been deposited in the Neisseria MLST database.
Previous SectionNext Section
SUPPLEMENTAL MATERIAL

Table S1, PDF file, 0.189 MB.
TABLE S1

Neisseria isolates screened for the presence of nL1.

Table S2, PDF file, 0.042 MB.
TABLE S2

Oligonucleotides used in this study.

Previous SectionNext Section
ACKNOWLEDGMENTS

We acknowledge M. Apicella, J. Dillard, K. Lee, R. Nicholas, P. Rice, W. Shafer, D. Trees, and W. Whittington for contributing Neisseria strains; J. Bodily for providing preparations of human genomic DNA; K. Clark for performing the bioinformatics screen that identified the nL1 sequence; D. Ward and M. Giovanni for facilitating the genomic sequencing of N. gonorrhoeae strains; M. Fitzgerald for providing genomic assemblies; M. Maiden for providing access to N. meningitidis genome sequences; K.-Y. Kim for assisting with the statistical analysis; and A. Chen and A. Hauser for critical reading of the manuscript.

This work was supported by NIH grants R01 AI044239 and R37 AI033493 to H.S.S. M.T.A. was partially supported by NIH fellowship F32AI080083.
Previous SectionNext Section
Footnotes

Citation Anderson, M. T., and H. S. Seifert. 2011. Opportunity and means: horizontal gene transfer from the human host to a bacterial pathogen. mBio 2(1):e00005-11. doi:10.1128/mBio.00005-11.

Received 6 January 2011
Accepted 12 January 2011
Published 15 February 2011

Copyright © 2011 Anderson and Seifert

This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported License, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original author and source are credited.
Previous Section

REFERENCES

1.↵
McDaniel T. K.,
Kaper J. B.
. 1997. A cloned pathogenicity island from enteropathogenic Escherichia coli confers the attaching and effacing phenotype on E. coli K-12. Mol. Microbiol. 23:399–407.
CrossRefMedline
2.↵
Lawrence J. G.,
Ochman H.
. 1997. Amelioration of bacterial genomes: rates of change and exchange. J. Mol. Evol. 44:383–397.
CrossRefMedline
3.↵
Goldman B. S.,
Kranz R. G.
. 1998. Evolution and horizontal transfer of an entire biosynthetic pathway for cytochrome c biogenesis: Helicobacter, Deinococcus, Archae and more. Mol. Microbiol. 27:871–873.
CrossRefMedline
4.↵
Davies J.,
Davies D.
. 2010. Origins and evolution of antibiotic resistance. Microbiol. Mol. Biol. Rev. 74:417–433.
Abstract/FREE Full Text
5.↵
Feil E.,
Zhou J.,
Smith J. Maynard,
Spratt B. G.
. 1996. A comparison of the nucleotide sequences of the adk and recA genes of pathogenic and commensal Neisseria species: evidence for extensive interspecies recombination within adk. J. Mol. Evol. 43:631–640.
CrossRefMedline
6.↵
Spratt B. G.,
Bowler L. D.,
Zhang Q. Y.,
Zhou J.,
Smith J. M.
. 1992. Role of interspecies transfer of chromosomal genes in the evolution of penicillin resistance in pathogenic and commensal Neisseria species. J. Mol. Evol. 34:115–125.
Medline
7.↵
Kroll J. S.,
Wilks K. E.,
Farrant J. L.,
Langford P. R.
. 1998. Natural genetic exchange between Haemophilus and Neisseria: intergeneric transfer of chromosomal genes between major human pathogens. Proc. Natl. Acad. Sci. U. S. A. 95:12381–12385.
Abstract/FREE Full Text
8.↵
Fudyk T. C.,
Maclean I. W.,
Simonsen J. N.,
Njagi E. N.,
Kimani J.,
Brunham R. C.,
Plummer F. A.
. 1999. Genetic diversity and mosaicism at the por locus of Neisseria gonorrhoeae. J. Bacteriol. 181:5591–5599.
Abstract/FREE Full Text
9.↵
Hobbs M. M.,
Alcorn T. M.,
Davis R. H.,
Fischer W.,
Thomas J. C.,
Martin I.,
Ison C.,
Sparling P. F.,
Cohen M. S.
. 1999. Molecular typing of Neisseria gonorrhoeae causing repeated infections: evolution of porin during passage within a community. J. Infect. Dis. 179:371–381.
Abstract/FREE Full Text
10.↵
Scott A. F.,
Schmeckpeper B. J.,
Abdelrazik M.,
Comey C. T.,
O’Hara B.,
Rossiter J. P.,
Cooley T.,
Heath P.,
Smith K. D.,
Margolet L.
. 1987. Origin of the human L1 elements: proposed progenitor genes deduced from a consensus DNA sequence. Genomics 1:113–125.
CrossRefMedline
11.↵
Cost G. J.,
Feng Q.,
Jacquier A.,
Boeke J. D.
. 2002. Human L1 element target-primed reverse transcription in vitro. EMBO J. 21:5899–5910.
CrossRefMedline
12.↵
Chung G. T.,
Yoo J. S.,
Oh H. B.,
Lee Y. S.,
Cha S. H.,
Kim S. J.,
Yoo C. K.
. 2008. Complete genome sequence of Neisseria gonorrhoeae NCCP11945. J. Bacteriol. 190:6035–6036.
Abstract/FREE Full Text
13.↵
Martin S. L.,
Bushman F. D.
. 2001. Nucleic acid chaperone activity of the ORF1 protein from the mouse LINE-1 retrotransposon. Mol. Cell. Biol. 21:467–475.
Abstract/FREE Full Text
14.↵
Khazina E.,
Weichenrieder O.
. 2009. Non-LTR retrotransposons encode noncanonical RRM domains in their first open reading frame. Proc. Natl. Acad. Sci. U. S. A. 106:731–736.
Abstract/FREE Full Text
15.↵
Kawai M.,
Uchiyama I.,
Kobayashi I.
. 2005. Genome comparison in silico in Neisseria suggests integration of filamentous bacteriophages by their own transposase. DNA Res. 12:389–401.
Abstract/FREE Full Text
16.↵
Skaar E. P.,
Lecuyer B.,
Lenich A. G.,
Lazio M. P.,
Perkins-Balding D.,
Seifert H. S.,
Karls A. C.
. 2005. Analysis of the Piv recombinase-related gene family of Neisseria gonorrhoeae. J. Bacteriol. 187:1276–1286.
Abstract/FREE Full Text
17.↵
Deitsch K. W.,
Carlton J. M.,
Wootton J. C.,
Wellems T. E.
. 2001. Host sequences in Plasmodium falciparum and Plasmodium vivax genomic DNA: horizontal transfer or contamination artifact? FEBS Lett. 491:164–165.
Medline
18.↵
Bennett J. S.,
Jolley K. A.,
Sparling P. F.,
Saunders N. J.,
Hart C. A.,
Feavers I. M.,
Maiden M. C.
. 2007. Species status of Neisseria gonorrhoeae: evolutionary and epidemiological inferences from multilocus sequence typing. BMC Biol. 5:35.
CrossRefMedline
19.↵
Apicella M. A.,
Ketterer M.,
Lee F. K.,
Zhou D.,
Rice P. A.,
Blake M. S.
. 1996. The pathogenesis of gonococcal urethritis in men: confocal and immunoelectron microscopic analysis of urethral exudates from men infected with Neisseria gonorrhoeae. J. Infect. Dis. 173:636–646.
Abstract/FREE Full Text
20.↵
Ovcinnikov N. M.,
Delektorskij V. V.
. 1971. Electron microscope studies of gonococci in the urethral secretions of patients with gonorrhoea. Br. J. Vener. Dis. 47:419–439.
Medline
21.↵
Duffin P. M.,
Seifert H. S.
. 2010. DNA uptake sequence-mediated enhancement of transformation in Neisseria gonorrhoeae is strain dependent. J. Bacteriol. 192:4436–4444.
Abstract/FREE Full Text
22.↵
Walker P. R.,
Sikorska M.
. 1994. Endonuclease activities, chromatin structure, and DNA degradation in apoptosis. Biochem. Cell Biol. 72:615–623.
Medline
23.↵
Brinkmann V.,
Reichard U.,
Goosmann C.,
Fauler B.,
Uhlemann Y.,
Weiss D. S.,
Weinrauch Y.,
Zychlinsky A.
. 2004. Neutrophil extracellular traps kill bacteria. Science 303:1532–1535.
Abstract/FREE Full Text
24.↵
Chayot R.,
Montagne B.,
Mazel D.,
Ricchetti M.
. 2010. An end-joining repair mechanism in Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 107:2141–2146.
Abstract/FREE Full Text
25.↵
Stohl E. A.,
Criss A. K.,
Seifert H. S.
. 2005. The transcriptome response of Neisseria gonorrhoeae to hydrogen peroxide reveals genes with previously uncharacterized roles in oxidative damage protection. Mol. Microbiol. 58:520–532.
CrossRefMedline


Top
 Profile  
Thanks  
PostPosted: 06 Jun 2012, 20:28 
Offline
Contributor
User avatar

Joined: 10 May 2012, 14:53
Posts: 533
81 times in 58 posts
Odalis wrote:
Know what's even more creepy? The two pahtalogical strains of Neisseria gonorrhoeae that cause the disease are also capable of transforming the hosts DNA. That is they are able to put their DNA into your DNA, or take some of your's back into themselves.


What could potentially come of this?


Top
 Profile  
Thanks  
PostPosted: 06 Jun 2012, 20:33 
Offline
Elite Contributor

Joined: 09 Jan 2011, 18:01
Posts: 2421
Location: Belgium
Thanks: 289
Thanked:
321 times in 255 posts
i also read about this, yet another reason to always use a condom

_________________
Only a man is able to determine what is best for him. Women and society in general never have his best interests in mind, and he is under no obligation to live his life according to what they want.


Top
 Profile  
Thanks  
PostPosted: 06 Jun 2012, 23:29 
Offline
Elite Contributor
User avatar

Joined: 24 Aug 2011, 19:10
Posts: 3392
Location: Fresno, California. USA
Thanks: 506
Thanked:
1250 times in 726 posts
or be with and share it with THE ONE

_________________
Men invented the Internet because women took over television


Top
 Profile  
Thanks  
The following users would like to thank gmartinfan for the above post:
Odalis
PostPosted: 07 Jun 2012, 00:55 
Offline
Elite Contributor

Joined: 28 Aug 2011, 17:55
Posts: 2359
Thanks: 979
Thanked:
219 times in 163 posts
Hopeless_Romantic wrote:
Odalis wrote:
Know what's even more creepy? The two pahtalogical strains of Neisseria gonorrhoeae that cause the disease are also capable of transforming the hosts DNA. That is they are able to put their DNA into your DNA, or take some of your's back into themselves.


What could potentially come of this?


Removing a chunk of DNA might be innocuous but it could also be deleterious in unpredictable ways. If part of a sequence is taken from only one strand, the next strand is could get get messed up. The short strand might reattach to the other end and whatever was coded for is no different, or the new combination reads a stop or different directions. This changes the protein made. A function is altered.


Top
 Profile  
Thanks  
PostPosted: 07 Jun 2012, 15:08 
Offline
Elite Contributor

Joined: 28 Aug 2011, 17:55
Posts: 2359
Thanks: 979
Thanked:
219 times in 163 posts
Not emerging, is fully emerged. In Japan from a sex worker's throat.

Quote:
Bad bug: Gonorrhea strain resists all antibiotics
Long-feared development has occurred; only question is whether it will spread
http://www.msnbc.msn.com/id/43689581/ns ... tibiotics/

For several years, public health officials have been concerned that gonorrhea, one of the most prevalent STDs in the world, might become resistant to the last widely available antibiotics used to treat it, a class of drugs called cephalosporins.

Don't miss these Health stories Courtesy of the ISMP Eye burns linked to Clear Care cleaner
Amid ongoing reports of burning eyes and emergency injuries, the makers of a popular contact lens solution have failed to adequately warn consumers about the dangers of using the product improperly, a patient safety group says.

.'Macho' dudes are more likely to sacrifice for the team
Does the sun make you sneeze? It's not just you
Men seek testosterone quick fix, with risks
Most breast-feeding moms quit earlier than planned
..Now, it has.

In the space of one week, infectious disease specialists have received a one-two punch of bad news that confirms those fears, including the discovery of a new, cephalosporin-resistant strain of the bacteria.

The percentage of U.S. gonorrhea cases that are less susceptible to the two cephalosporins used to treat it, cefixime, taken orally, and ceftriaxone, injected, is on the rise, according to the Centers for Disease Control and Prevention's latest Morbidity and Mortality Weekly Report

The Gonococcal Isolate Surveillance Project, a lookout program designed to spot resistance, found that 1.4 percent of patient samples showed growing ability to defeat cefixime in 2010 compared to just .2 percent in 2000. Resistance to ceftiaxone grew from .1 percent to .3 percent during the same period.

Then Sunday, a Japanese-European team presenting data at the International Society for Sexually Transmitted Disease Research meeting in Quebec City, Canada, publicly announced the discovery of a new strain of gonorrhea, H041, that displays a strong resistance to ceftriaxone.

"This is both an alarming and a predictable discovery," said one of the project's lead researchers, Dr. Magnus Unemo of the Swedish Reference Laboratory for Pathogenic Neisseria.

H041, first found in a the pharynx of a Japanese sex worker, is 4- to 8-fold more resistant to ceftriaxone — the only form of cephalosporin used to treat that type of gonorrhea in the throat — than any strain ever found.

Resistant strain could arrive in U.S. soon
When researchers grew H041 with other gonorrhea strains, genetic recombination increased those strains’ resistance by up to 500-fold.

“Why this is so concerning is that there are no other treatment options besides cephalosporins right now,” said Dr. Kimberly Workowski, an STD infection expert at Emory University. “For pharyngeal infection, oral drugs do not work and ceftiaxone is the only injectable.”

What’s more, she explained, if history is any guide, the H041 strain will soon arrive in the U.S.

Workowski and other experts stressed that it’s too soon to panic. By increasing dosages —though at greater risk of toxic side effects — and combining the cephalosporins with azithromycin or doxycycline, both strategies the CDC began recommending last year, the vast majority of gonorrhea cases will be effectively treated for now.

But, said Dr. Edward Hook, professor of medicine at the University of Alabama at Birmingham, experts face a serious and growing problem that will be debated.

"Could we be developing a problem that is far worse and more problematic? Absolutely," said, Hook, an author of the MMWR report. "It is something that needs to be attended to not just for gonorrhea but for other” bacterial infections for which antibiotic resistance is growing.



Top
 Profile  
Thanks  
PostPosted: 07 Jun 2012, 20:46 
Offline
New Poster

Joined: 27 May 2012, 11:04
Posts: 16
Thanks: 10
Thanked:
3 times in 3 posts
The bright side is that most incels aren't likely to get it ! We will rule the earth ;)


Top
 Profile  
Thanks  
Display posts from previous:  Sort by  
Post new topic Reply to topic  [ 9 posts ] 

All times are UTC [ DST ]


Who is online

Users browsing this forum: No registered users and 3 guests


You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum
You cannot post attachments in this forum

Jump to:  
Powered by phpBB® Forum Software © phpBB Group